Biofrontera confirms talks with Biofrontera AG on merger or license restructuring

Biofrontera Inc.

Negotiations with Biofrontera AG include possible combination of the two companies.
Alternative: adjustment to license/supply agreement transferring certain rights to Biofrontera Inc.
Potential reduction in transfer price for licensed products sold in the US.
Terms not yet established; subject to definitive agreements and conditions.
Disclosure follows June 10, 2025 announcement by Biofrontera AG's management board.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.